GlassScriptPhysician profile
Subhash K Patel
NPI 1952485997
$1,196.19
in general payments reported to CMS, 2019-2025
16 companies · $933 in 2025
The $933 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.85 · 2023: $56.09 · 2024: $121 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019 · Education: $91.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.09 |
| Education | $91.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $196.46 | 2023-2025 | |
| Lilly USA, LLC | $154.60 | 2024-2025 | Emgality, Amyvid, Kisunla |
| Teva Pharmaceuticals USA, INC. | $146.50 | 2025 | Ajovy, Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $89.51 | 2025 | Wainua |
| Sk Life Science, INC. | $86.16 | 2025 | Xcopri |
| Merck Sharp & Dohme LLC | $85.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $60.99 | 2024-2025 | |
| Abbvie INC. | $59.79 | 2025 | |
| Genentech USA, INC. | $58.75 | 2023-2025 | Ocrevus Zunovo, Ocrevus |
| Janssen Biotech, INC. | $58.20 | 2025 | |
| Tg Therapeutics, INC. | $42.82 | 2025 | |
| Genzyme Corporation | $42.71 | 2025 | |
| Vanda Pharmaceuticals INC. | $38.09 | 2025 | Ponvory |
| Lundbeck LLC | $29.69 | 2025 | Vyepti |
| Celgene Corporation | $23.84 | 2025 | Zeposia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $22.23 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.